XLR11 6-hydroxyindole metabolite |
| カタログ番号GC45166 |
XLR11は、テトラメチルシクロプロピル基を特徴とする合成カンナビノイド（CB）であり、末梢のCB2受容体に対して中枢のCB1受容体よりも選択的であると報告されています。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1630022-98-8
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
XLR11 is a synthetic cannabinoid (CB) featuring a tetramethylcyclopropyl group, which reportedly confers selectivity for the peripheral CB2 receptor over the central CB1 receptor. XLR11 also has an N-(5-fluoropentyl) chain, which increases binding to both CB receptors. XLR11 6-hydroxyindole metabolite is an expected minor monohydroxylated urinary metabolite of XLR11. The biological and toxicological properties of this compound have not been evaluated. This product is intended for forensic and research applications.
Average Rating: 5 (Based on Reviews and 34 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *